Piperacillin + Tazobactam TAZOLYCIN
Piperacillin + Tazobactam TAZOLYCIN
What is it?
Tazolycin is an intravenous antibiotic combining:
-
Piperacillin – a broad-spectrum penicillin
-
Tazobactam – a β‑lactamase inhibitor that protects piperacillin from bacterial resistance
What it treats
Used to tackle moderate to severe bacterial infections, including:
-
Hospital-acquired and ventilator-associated pneumonia
-
Complicated urinary, skin & soft tissue, intra-abdominal infections, including diabetic foot
-
Pelvic inflammatory disease and post-partum uterine infections
-
Sepsis, febrile neutropenia, and other serious systemic infections
Dosage & administration
-
Supplied as a powder for IV infusion (e.g., 4 g/0.5 g per vial) en.wikipedia.org+7labeling.pfizer.com+7nps.org.au+7
-
Adults usually receive 4 g/0.5 g IV every 6–8 hours, depending on infection type and kidney function
-
Treatment typically extends 5–14 days, guided by infection severity and response labeling.pfizer.com
_Adjustments are made for renal impairment, pediatric patients, and dosing during dialysis. No alteration usually necessary for liver issues labeling.pfizer.com
What is it?
Tazolycin is an intravenous antibiotic combining:
-
Piperacillin – a broad-spectrum penicillin
-
Tazobactam – a β‑lactamase inhibitor that protects piperacillin from bacterial resistance
What it treats
Used to tackle moderate to severe bacterial infections, including:
-
Hospital-acquired and ventilator-associated pneumonia
-
Complicated urinary, skin & soft tissue, intra-abdominal infections, including diabetic foot
-
Pelvic inflammatory disease and post-partum uterine infections
-
Sepsis, febrile neutropenia, and other serious systemic infections
Dosage & administration
-
Supplied as a powder for IV infusion (e.g., 4 g/0.5 g per vial) en.wikipedia.org+7labeling.pfizer.com+7nps.org.au+7
-
Adults usually receive 4 g/0.5 g IV every 6–8 hours, depending on infection type and kidney function
-
Treatment typically extends 5–14 days, guided by infection severity and response labeling.pfizer.com
_Adjustments are made for renal impairment, pediatric patients, and dosing during dialysis. No alteration usually necessary for liver issues labeling.pfizer.com
New Arrival
Featured Products
Related products
-
InjectablesCeftriaxone as Sodium (SITIXON) 1 g
-
InjectablesCefuroxime as Sodium (DANOXIME) 750 MG
-
InjectablesOMEPRAZOLE (SIDPRAZOLE) 40 mg
-
InjectablesOxacillin as Sodium (PEOXA) 500 MG
-
InjectablesTetanus Antitoxin (IMATET) 1500 IU/0.7 mL
